Emily Bodnar
Stock Analyst at HC Wainwright & Co.
(1.02)
# 3,844
Out of 5,056 analysts
335
Total ratings
28.33%
Success rate
-20.94%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Emily Bodnar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANAB AnaptysBio | Maintains: Buy | $59 → $52 | $33.23 | +56.49% | 12 | Nov 11, 2025 | |
| SANA Sana Biotechnology | Maintains: Buy | $11 → $9 | $4.15 | +116.87% | 12 | Nov 7, 2025 | |
| CNTX Context Therapeutics | Maintains: Buy | $4 → $5 | $1.19 | +320.17% | 13 | Nov 6, 2025 | |
| VTYX Ventyx Biosciences | Upgrades: Buy | $18 | $9.40 | +91.49% | 16 | Nov 5, 2025 | |
| NVCR NovoCure | Maintains: Buy | $38 → $42 | $11.67 | +259.90% | 19 | Oct 30, 2025 | |
| RCUS Arcus Biosciences | Maintains: Buy | $24 → $28 | $20.45 | +36.92% | 6 | Oct 29, 2025 | |
| RAPT RAPT Therapeutics | Maintains: Buy | $27 → $72 | $29.48 | +144.27% | 3 | Oct 27, 2025 | |
| OLMA Olema Pharmaceuticals | Reiterates: Buy | $28 | $8.22 | +240.63% | 21 | Oct 20, 2025 | |
| SNTI Senti Biosciences | Initiates: Buy | $12 | $1.88 | +538.30% | 1 | Oct 14, 2025 | |
| TGTX TG Therapeutics | Assumes: Buy | $60 | $31.27 | +91.88% | 1 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.83 | - | 14 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $4.48 | +413.39% | 20 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $56 | $43.82 | +27.80% | 2 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $40 | $10.16 | +293.70% | 15 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $35 | $13.83 | +153.07% | 14 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $31.08 | +15.83% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $0.96 | +736.65% | 25 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $9 | $3.29 | +173.97% | 2 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $20 | $1.79 | +1,017.32% | 10 | Jul 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $9.04 | +298.23% | 9 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $115 | $90.20 | +27.49% | 13 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $12 | $3.56 | +237.08% | 1 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $560 → $280 | $8.85 | +3,064.20% | 17 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.60 | +400.00% | 6 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $5.89 | +409.34% | 7 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $2.19 | +769.57% | 12 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.97 | +813.71% | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $183 | $3.87 | +4,618.60% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.80 | +773.80% | 14 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.25 | - | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.52 | +1,084.21% | 1 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $0.80 | +4,050.94% | 14 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.56 | - | 1 | Apr 25, 2024 |
AnaptysBio
Nov 11, 2025
Maintains: Buy
Price Target: $59 → $52
Current: $33.23
Upside: +56.49%
Sana Biotechnology
Nov 7, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $4.15
Upside: +116.87%
Context Therapeutics
Nov 6, 2025
Maintains: Buy
Price Target: $4 → $5
Current: $1.19
Upside: +320.17%
Ventyx Biosciences
Nov 5, 2025
Upgrades: Buy
Price Target: $18
Current: $9.40
Upside: +91.49%
NovoCure
Oct 30, 2025
Maintains: Buy
Price Target: $38 → $42
Current: $11.67
Upside: +259.90%
Arcus Biosciences
Oct 29, 2025
Maintains: Buy
Price Target: $24 → $28
Current: $20.45
Upside: +36.92%
RAPT Therapeutics
Oct 27, 2025
Maintains: Buy
Price Target: $27 → $72
Current: $29.48
Upside: +144.27%
Olema Pharmaceuticals
Oct 20, 2025
Reiterates: Buy
Price Target: $28
Current: $8.22
Upside: +240.63%
Senti Biosciences
Oct 14, 2025
Initiates: Buy
Price Target: $12
Current: $1.88
Upside: +538.30%
TG Therapeutics
Oct 6, 2025
Assumes: Buy
Price Target: $60
Current: $31.27
Upside: +91.88%
Sep 29, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.83
Upside: -
Sep 10, 2025
Reiterates: Buy
Price Target: $23
Current: $4.48
Upside: +413.39%
Sep 4, 2025
Reiterates: Buy
Price Target: $56
Current: $43.82
Upside: +27.80%
Aug 27, 2025
Maintains: Buy
Price Target: $32 → $40
Current: $10.16
Upside: +293.70%
Aug 15, 2025
Upgrades: Buy
Price Target: $35
Current: $13.83
Upside: +153.07%
Aug 13, 2025
Reiterates: Buy
Price Target: $36
Current: $31.08
Upside: +15.83%
Aug 11, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $0.96
Upside: +736.65%
Jul 22, 2025
Maintains: Buy
Price Target: $10 → $9
Current: $3.29
Upside: +173.97%
Jul 7, 2025
Maintains: Buy
Price Target: $40 → $20
Current: $1.79
Upside: +1,017.32%
Jul 1, 2025
Reiterates: Buy
Price Target: $36
Current: $9.04
Upside: +298.23%
Jun 16, 2025
Reiterates: Buy
Price Target: $115
Current: $90.20
Upside: +27.49%
Jun 11, 2025
Assumes: Buy
Price Target: $12
Current: $3.56
Upside: +237.08%
Apr 16, 2025
Maintains: Buy
Price Target: $560 → $280
Current: $8.85
Upside: +3,064.20%
Apr 1, 2025
Reiterates: Buy
Price Target: $8
Current: $1.60
Upside: +400.00%
Mar 31, 2025
Reiterates: Buy
Price Target: $30
Current: $5.89
Upside: +409.34%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $2.19
Upside: +769.57%
Mar 27, 2025
Reiterates: Buy
Price Target: $18
Current: $1.97
Upside: +813.71%
Mar 26, 2025
Reiterates: Buy
Price Target: $183
Current: $3.87
Upside: +4,618.60%
Mar 26, 2025
Reiterates: Buy
Price Target: $7
Current: $0.80
Upside: +773.80%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.25
Upside: -
Feb 3, 2025
Reiterates: Buy
Price Target: $18
Current: $1.52
Upside: +1,084.21%
Nov 15, 2024
Reiterates: Buy
Price Target: $33
Current: $0.80
Upside: +4,050.94%
Apr 25, 2024
Reiterates: Neutral
Price Target: n/a
Current: $3.56
Upside: -